Form 4 Tracker
Nancy Thornberry

Director · 4 filings · Latest: Sep 2, 2026

Denali Therapeutics Inc.
Schrodinger, Inc.
VERTEX PHARMACEUTICALS INC / MA
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
DNLI
Nancy ThornberryDirectorSep 2, 2026
Sale
$22.9011,439$261.9K19,686
DNLI
NANCY THORNBERRY—Sep 2, 2026
Proposed Sale
$23.2711,439$266.1K—